ARS Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-15 07:50:37 ET SPRY

Published on 05/15/2026 at 07:50 am EDT

ARS Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was USD 2.74 million. Revenue was USD 22.68 million compared to USD 7.97 million a year ago.

Net loss was USD 60.62 million compared to USD 33.94 million a year ago. Basic loss per share from continuing operations was USD 0.61 compared to USD 0.35 a year ago. Diluted loss per share from continuing operations was USD 0.61 compared to USD 0.35 a year ago.